Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernews.google.com
"Anti-CD38" - Google News
Get the latest updates from "Anti-CD38" - Google News directly as they happen.
Follow now < 10 followers
Latest posts
Last updated about 2 years ago
U.S. Stocks Showing A Lack Of Direction Following Recent Volatility - Nasdaq
about 2 years ago
U.S. Stocks Showing A Lack Of Direction Following Recent Volatility Nasdaq
MorphoSys AG (MOR) Q4 2021 Earnings Call Transcript - The Motley Fool
about 2 years ago
MorphoSys AG (MOR) Q4 2021 Earnings Call Transcript The Motley Fool
Dow To Participate In J.P. Morgan Industrials Conference At 11:20 AM ET - Nasdaq
about 2 years ago
Dow To Participate In J.P. Morgan Industrials Conference At 11:20 AM ET...
Sarclisa Extends Survival in Recent Data and Speeds SubQ Administration in Multiple Myeloma - Myeloma Crowd News
about 2 years ago
Sarclisa Extends Survival in Recent Data and Speeds SubQ Administration in Multiple...
Other news to note for March 16, 2022 - BioWorld Online
about 2 years ago
Other news to note for March 16, 2022 BioWorld Online
Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non–small cell lung cancer - Science
about 2 years ago
Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in...
Sarclisa Extends Survival in Recent Data and Speeds SubQ Administration in Multiple Myeloma - Myeloma Crowd News
about 2 years ago
Sarclisa Extends Survival in Recent Data and Speeds SubQ Administration in Multiple...
Sanofi reveals $330m collaboration with Blackstone Life Sciences - PMLiVE
about 2 years ago
Sanofi reveals $330m collaboration with Blackstone Life Sciences PMLiVE
Karyopharm Announces Upcoming Presentations of Phase 3 SIENDO Study of Selinexor in Patients with Advanced or Recurrent Endometrial Cancer - Stockhouse
about 2 years ago
Karyopharm Announces Upcoming Presentations of Phase 3 SIENDO Study of Selinexor in...
Sanofi and Blackstone €300 million collaboration to advance multiple myeloma treatment - European Pharmaceutical Review
about 2 years ago
Sanofi and Blackstone €300 million collaboration to advance multiple myeloma treatment European...
Costa Reviews Regimens for Patients With Transplant-Eligible and Transplant-Ineligible NDMM - Targeted Oncology
about 2 years ago
Costa Reviews Regimens for Patients With Transplant-Eligible and Transplant-Ineligible NDMM Targeted Oncology
Sanofi Rebounds with $329M Blackstone Infusion for Multiple Myeloma Drug - BioSpace
about 2 years ago
Sanofi Rebounds with $329M Blackstone Infusion for Multiple Myeloma Drug BioSpace